As anaesthetists raise concerns about surgical risks linked to GLP-1s, GPs say open conversations about medication use are more important than ever.

As research reveals marked differences in people’s pollen symptoms, ‘personalised forecasting’ can help patients understand risks.

A new AIHW report reveals the number of people on multiple medications is expected to rise. How can GPs help mitigate the risks?

It’s hoped the findings help GPs identify risk earlier and give patients ‘a better understanding before it becomes more entrenched’.

A ‘deeply concerning’ Four Corners investigation alleges providers are putting profit ahead of veteran wellbeing, and cutting out regular general practice.

In a submission on proposed changes, it says fully delegating this task to assessors who do not know the patient would be ‘problematic’.

It aims to translate research into better care for patients and communities, supporting projects on ageing, chronic disease, and AI.

ATAGI now recommends Qdenga for patients with a history of dengue fever who are travelling to endemic areas.

A Parliamentary inquiry found ‘compelling evidence’ of the need for major change, as the RACGP calls for a health-first approach.

A long list of 1 November changes includes four new phone attendance items, alongside three-year-old health check items.

Its new position statement sets out how UCCs can better connect with general practice, including through profession-led standards.

A new study identifies four phases where GPs can have meaningful and structured discussions with dementia patients.

Giving MenB vaccines alongside routine childhood immunisations may lower the likelihood of side effects, according to new research.

The first stage of the reform is now live, and with GPs set to play a central role in early intervention and family support, what is changing?

The TGA has alerted doctors that two brands of diltiazem 360 mg controlled-release capsules are being discontinued in Australia.

SPONSORED: General practice is uniquely placed to identify cognitive decline, enabling earlier access to support and treatment.

An RACGP expert hopes a new study’s findings lead to a cure for the ‘very distressing’ condition of persistent bacterial vaginosis.

An evaluation says the Tasmanian trial improved access to care, but the RACGP argues patient outcomes were not adequately measured.

New AIHW figures reveal increases in HbA1c monitoring, CVD assessment and cervical screening, based on data from almost 5900 practices.

Three months into a 12-month transition, the RACGP welcomed the assurance that arrangements are still being explored as practices adapt to new Medicare processes.